Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com
Company Details
- Employees
- 367
- Founded
- -
- Address
- 16, Rue D'ankara, Strasbourg,grand Est 67000,france
- Phone
- +33 0 368 330 200
- in****@****rma.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- novalix-pharma.com
- Keywords
- Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, Chemical process research, DMPK, ADME.
- HQ
- Strasbourg, Grand Est
Novalix Questions
Novalix's helpline number is +33 0 368 330 200
Novalix's website is novalix-pharma.com
Novalix's LinkedIn profile is https://fr.linkedin.com/company/novalix
Novalix has
367 employees.
View email and phone details for 367
employees at Novalix.
Novalix's industry is
Biotechnology Research
Novalix's top competitors are
Sanofi,
Domain Therapeutics,
Edelris,
Octapharma France,
Novartis,
Servier,
Inoviem Scientific,
Polypeptide Group,
Galapagos,
Biosynex Pharma.
Novalix's support email address is info@novalix-pharma.com
Novalix's categories are Biotechnology Research
Novalix's founding year is 2002
